PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY
Disorders of intermediary metabolism in the glycolysis cycles and fatty acids oxidation play a major role in heart and brain lesions of vascular origin. Features of the free-radical processes in various forms of vascular disease are presented. Differences within the free-radical processes reflecting...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | http://www.rpcardio.ru/jour/article/view/11 |
| _version_ | 1827845871070347264 |
|---|---|
| author | S. A. Rumyantseva R. G. Oganov V. A. Stupin E. V. Silina A. S. Orlova S. B. Bolevich V. V. Afanasev E. N. Kabaeva S. A. Volik |
| author_facet | S. A. Rumyantseva R. G. Oganov V. A. Stupin E. V. Silina A. S. Orlova S. B. Bolevich V. V. Afanasev E. N. Kabaeva S. A. Volik |
| author_sort | S. A. Rumyantseva |
| collection | DOAJ |
| description | Disorders of intermediary metabolism in the glycolysis cycles and fatty acids oxidation play a major role in heart and brain lesions of vascular origin. Features of the free-radical processes in various forms of vascular disease are presented. Differences within the free-radical processes reflecting the severity of tissue energy deficit are shown in stroke patients with concomitant ischemic heart disease, atrial fibrillation, and diabetes mellitus. Various aspects of the treatment of patients with vascular comorbidity are presented with the focus on correction of intermediary metabolism disorders. Complex energy correcting therapy including beta-oxidation blocker (meldonium) is discussed. |
| first_indexed | 2024-03-12T09:04:39Z |
| format | Article |
| id | doaj.art-52584ec38c524411a2c51c947c7988ca |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-03-12T09:04:39Z |
| publishDate | 2015-09-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-52584ec38c524411a2c51c947c7988ca2023-09-02T15:22:14ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-019331632210.1234/1819-6446-2013-3-316-32211PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITYS. A. Rumyantseva0R. G. Oganov1V. A. Stupin2E. V. Silina3A. S. Orlova4S. B. Bolevich5V. V. Afanasev6E. N. Kabaeva7S. A. Volik8Российский национальный исследовательский медицинский университет имени Н.И. Пирогова, МоскваГосударственный научно-исследовательский центр профилактической медицины, МоскваРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова, МоскваПервый Московский медицинский университет имени И.М. Сеченова, МоскваПервый Московский медицинский университет имени И.М. Сеченова, МоскваПервый Московский медицинский университет имени И.М. Сеченова, МоскваСеверо-Западный государственный медицинский университет имени. И.И. Мечникова, Санкт-ПетербургРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова, МоскваРоссийский национальный исследовательский медицинский университет имени Н.И. Пирогова, МоскваDisorders of intermediary metabolism in the glycolysis cycles and fatty acids oxidation play a major role in heart and brain lesions of vascular origin. Features of the free-radical processes in various forms of vascular disease are presented. Differences within the free-radical processes reflecting the severity of tissue energy deficit are shown in stroke patients with concomitant ischemic heart disease, atrial fibrillation, and diabetes mellitus. Various aspects of the treatment of patients with vascular comorbidity are presented with the focus on correction of intermediary metabolism disorders. Complex energy correcting therapy including beta-oxidation blocker (meldonium) is discussed.http://www.rpcardio.ru/jour/article/view/11сосудистая коморбидностьинфаркт миокардаишемическая болезнь сердцаострый инсультбета-окисление жирных кислотблокаторы бета-окислениякомплексная цитопротекция |
| spellingShingle | S. A. Rumyantseva R. G. Oganov V. A. Stupin E. V. Silina A. S. Orlova S. B. Bolevich V. V. Afanasev E. N. Kabaeva S. A. Volik PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY Рациональная фармакотерапия в кардиологии сосудистая коморбидность инфаркт миокарда ишемическая болезнь сердца острый инсульт бета-окисление жирных кислот блокаторы бета-окисления комплексная цитопротекция |
| title | PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY |
| title_full | PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY |
| title_fullStr | PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY |
| title_full_unstemmed | PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY |
| title_short | PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY |
| title_sort | problems and prospects of intermediary metabolism correction in patients with vascular comorbidity |
| topic | сосудистая коморбидность инфаркт миокарда ишемическая болезнь сердца острый инсульт бета-окисление жирных кислот блокаторы бета-окисления комплексная цитопротекция |
| url | http://www.rpcardio.ru/jour/article/view/11 |
| work_keys_str_mv | AT sarumyantseva problemsandprospectsofintermediarymetabolismcorrectioninpatientswithvascularcomorbidity AT rgoganov problemsandprospectsofintermediarymetabolismcorrectioninpatientswithvascularcomorbidity AT vastupin problemsandprospectsofintermediarymetabolismcorrectioninpatientswithvascularcomorbidity AT evsilina problemsandprospectsofintermediarymetabolismcorrectioninpatientswithvascularcomorbidity AT asorlova problemsandprospectsofintermediarymetabolismcorrectioninpatientswithvascularcomorbidity AT sbbolevich problemsandprospectsofintermediarymetabolismcorrectioninpatientswithvascularcomorbidity AT vvafanasev problemsandprospectsofintermediarymetabolismcorrectioninpatientswithvascularcomorbidity AT enkabaeva problemsandprospectsofintermediarymetabolismcorrectioninpatientswithvascularcomorbidity AT savolik problemsandprospectsofintermediarymetabolismcorrectioninpatientswithvascularcomorbidity |